Recombinant Human CES2 Protein(HEK293)，His

CES2 (Carboxylesterase 2) is an important enzyme belonging to the carboxylesterase family, primarily involved in the hydrolysis of ester bonds in various substrates, including drugs, lipids, and xenobiotics. Understanding CES2's structure and function is crucial due to its significant role in drug metabolism and detoxification processes within the human body. Impairments or variations in CES2 activity can lead to altered drug efficacy and toxicity, highlighting its clinical relevance. Studies have shown that CES2 exhibits polymorphism, which can result in differing metabolic rates among individuals, thereby influencing therapeutic outcomes. Furthermore, CES2 has been implicated in the metabolism of prodrugs, which are inactive compounds that become pharmacologically active after metabolic conversion. Given the increasing complexity of drug development and the rise of personalized medicine, research into CES2 recombinant proteins has gained impetus. By producing and characterizing CES2 in a recombinant form, scientists can explore its enzymatic properties, substrate specificity, and interactions with inhibitors or activators, paving the way for enhanced drug formulations and individualized treatment approaches. Developing a better understanding of CES2 also contributes to the broader field of biochemistry and pharmacology, allowing for improved strategies in combating diseases and optimizing therapeutic regimens. With advancements in molecular biology techniques, the investigation of CES2's structure-function relationships continues to unfold, underscoring its importance in both scientific research and clinical applications.